Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02272595 · ClinicalTrials.gov registry record
Rational Therapeutics Based on Matched Tumor and Normal Tissue
A clinical trial, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- 3
- Enrollment target
NCT02272595: Completed study, sponsored by M.D. Anderson Cancer Center.
NCT02272595 is a clinical trial that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 3 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02272595 has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- 3 participants
- Enrollment target
Study Summary
The goal of this laboratory research study is to learn if using molecular information (matched therapy) or not using molecular information and having the study doctor choose the therapy based on your past experience are more effective ways to choose the best cancer treatment for you. This is an investigational study. Up to 200 participants will take part in this study. Up to 50 will be enrolled at MD Anderson.
Interventions
- OTHER Treatment Based on Genetic Mutation
- OTHER Treatment Based on No Genetic Mutation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2014-11-04 |
| Est. Completion | 2022-01-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02272595
The ClinicalTrials.gov registry entry for NCT02272595 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Treatment Based on Genetic Mutation is the first listed.
NCT02272595 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02272595 about?
NCT02272595 is a clinical study titled "Rational Therapeutics Based on Matched Tumor and Normal Tissue". The goal of this laboratory research study is to learn if using molecular information (matched therapy) or not using molecular information and having the study doctor choose the therapy based on your past experience are more effective ways to choose the best cancer treatment for you. This is an inv...
What is the current status of trial NCT02272595?
This trial is currently completed. The enrollment target is 3 participants. The study started on 2014-11-04. Estimated completion is 2022-01-11.
What interventions are being tested in trial NCT02272595?
The interventions under investigation include: Treatment Based on Genetic Mutation (OTHER), Treatment Based on No Genetic Mutation (OTHER).
Who is sponsoring clinical trial NCT02272595?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.